← Voltar aos artigos

health

Health & Medicine

The FDA has approved a new drug that could extend survival for late-stage pancreatic cancer patients, offering potential hope for a disease with historically poor outcomes.

HIGH confiança neutral tom

Cobertura (693 artigos)

← Anterior Página 5 de 29 Próximo →
Fale Conosco FAQ